Edwards Lifesciences Corporation EW
86.29
0.56
0.65%
as of 25 Sep
- Market cap
- $49.4B
- P/E
- 49.6×
Follow EW
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Edwards Lifesciences Corporation (EW) P/E ratio
As of 25 September 2026, Edwards Lifesciences Corporation (EW) trades at a P/E ratio of 49.6×. Over the past ten years it has ranged from 9.3× (October 2024) to 77.0× (June 2021); the current reading is higher than 79% of that period. That is above the Medical Devices industry median of 22.2× and above the Healthcare sector median of 22.7×.
P/E ratio, daily
Annual
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 46.3× | 336.84% |
| FY2024 | 10.6× | (67.58%) |
| FY2023 | 32.7× | 7.92% |
| FY2022 | 30.3× | (43.37%) |
| FY2021 | 53.5× | (22.74%) |
| FY2020 | 69.3× | 49.11% |
| FY2019 | 46.5× | 4.36% |
| FY2018 | 44.5× | 10.46% |
| FY2017 | 40.3× | 12.68% |
| FY2016 | 35.8× | 3.94% |
Quarterly
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 52.0× | 22.70% |
| Mar 2026 | 42.4× | (8.55%) |
| Dec 2025 | 46.3× | 38.81% |
| Sep 2025 | 33.4× | 197.46% |
| 42 more quarters | Free account |
Against its own ten years
Low 9.3×
High 77.0×
Ten-year median
39.7×
Current reading's percentile
79
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| GEHC GE HealthCare Technologies Inc. compare | 15.3× |
| BSX Boston Scientific Corporation compare | 17.7× |
| PHG Koninklijke Philips N.V. compare | 18.2× |
| MDT Medtronic PLC compare | 21.7× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 22.0× |
| STE STERIS plc compare | 25.4× |
| SYK Stryker Corporation compare | 28.0× |
| DXCM DexCom, Inc. compare | 33.4× |
| EW Edwards Lifesciences Corporation | 49.6× |
| Medical Devices industry median | 22.2× |
| Healthcare sector median | 22.7× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on EW
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement